Diphenoxylate Hydrochloride and Atropine Sulfate
- Product NDC
- 68071-4063
- Requested package NDC
- 68071-4063-3
- 11-digit product format
- 680714063
- Labeler code
- 68071
- Product ID
- 68071-4063_1d8dd9e3-f2b7-7894-e063-6394a90a29d3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Diphenoxylate Hydrochloride and Atropine Sulfate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA086727
- Marketing category
- ANDA
- Marketing start
- 2017-06-20
- Substance
- ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
- Active strength
- .025; 2.5 mg/1; mg/1
- Pharmacologic classes
- Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A086727-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A086727-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | cb3db0bc1861… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A086727-001 | AA | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A086727-001 | AA | 1 | 31067a03dcf5… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A086727-001 | AA | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A086727-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A086727-001 | AA | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A086727-001 | AA | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A086727-001 | AA | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A086727-001 | AA | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A086727-001 | AA | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A086727-001 | AA | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A086727-001 | AA | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A086727-001 | AA | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A086727-001 | AA | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A086727-001 | AA | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A086727-001 | AA | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A086727-001 | AA | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A086727-001 | AA | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A086727-001 | AA | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A086727-001 | AA | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A086727-001 | AA | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A086727-001 | AA | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A086727-001 | AA | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A086727-001 | AA | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A086727-001 | AA | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A086727-001 | AA | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A086727-001 | AA | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A086727-001 | AA | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A086727-001 | AA | 1 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A086727-001 | AA | 1 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Diphenoxylate Hydrochloride and Atropine Sulfate
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DIPHENOXYLATE HYDROCHLORIDE | .025 mg/1 |
| ATROPINE SULFATE | 2.5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| W24OD7YW48 | Internal UNII lookup |
| 03J5ZE7KA5 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1190572 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 575c38b4-7ec0-6d25-e053-2a91aa0a80fc | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c78bd43-efb4-4aeb-b7d8-eff1532f7822 | Product name | 4 | 20250801 |
| 41231c1e-8789-4da7-ac52-77fa90a85bf5 | Product name | 2 | 20250304 |
| e77ab9a2-80cf-4832-bff0-469bbc7cbcd0 | Product name | 2 | 20250214 |
| 5f84b7a7-523a-f042-dffb-1dadcd9b2407 | Product name | 4 | 20240110 |
| 0cbc6fb2-78c0-4b88-98f0-a4cc76ff95ca | Product name | 1 | 20230719 |
| 04cd5dc0-102f-46cb-8dbc-ca38dd2628d0 | Product name | 3 | 20230317 |
| dfd25202-b8d2-4628-9213-f3e0f9eafce5 | Product name | 4 | 20210513 |
| 4199bf9b-4718-828a-6dd6-ac2fbbd61687 | Product name | 1 | 20140508 |
| 4edd8af5-cea7-ae42-8023-e91c5335db1d | Product name | 1 | 20140508 |
| d3908afb-7784-440f-c406-88294732d36a | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-4063-1 | Diphenoxylate Hydrochloride and Atropine Sulfate | 10 in 1 BOTTLE | TABLET | 10 | 6 | |
| 68071-4063-2 | Diphenoxylate Hydrochloride and Atropine Sulfate | 20 in 1 BOTTLE | TABLET | 20 | 6 | |
| 68071-4063-3 | Diphenoxylate Hydrochloride and Atropine Sulfate | 30 in 1 BOTTLE | TABLET | 30 | 6 | |
| 68071-4063-5 | Diphenoxylate Hydrochloride and Atropine Sulfate | 15 in 1 BOTTLE | TABLET | 15 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-4063 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE TABLET [NUCARE PHARMACEUTICALS,INC.] | 6 | Current NDC, Legacy NDC, 4 package rows | 20240720_575c38b4-7ec0-6d25-e053-2a91aa0a80fc.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | A-S Medication Solutions | f94a0189-40d2-42e0-8d2b-c9dc433faad1 | 2026-07-29 | Warnings, Adverse reactions | 086727 ANDA086727 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Bryant Ranch Prepack | bd08ed90-dd26-4629-83c0-0f75af6ebb95 | 2026-05-21 | Warnings, Adverse reactions | 086727 ANDA086727 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Bryant Ranch Prepack | 64be1529-f290-422c-a076-32c0e1ced1a1 | 2026-03-24 | Warnings, Adverse reactions | 086727 ANDA086727 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | ANI Pharmaceuticals, Inc. | 73dc5f91-d562-44c5-a556-66c96ed1dd82 | 2025-12-22 | Warnings, Adverse reactions | 086727 ANDA086727 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | NuCare Pharmaceuticals,Inc. | 575c38b4-7ec0-6d25-e053-2a91aa0a80fc | 2024-07-18 | Warnings, Adverse reactions | 086727 ANDA086727 68071-4063-3 68071-4063 68071406303 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Proficient Rx LP | c832ef16-a06e-4e47-9df3-ab33bdfa6e56 | 2020-03-01 | Warnings, Adverse reactions | 086727 ANDA086727 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Aphena Pharma Solutions - Tennessee, LLC | 435e5e75-5a4c-4806-8d9e-d4be3fef9229 | 2017-08-31 | Warnings, Adverse reactions | 086727 ANDA086727 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1190572 | diphenoxylate HCl 2.5 MG / atropine sulfate 0.025 MG Oral Tablet | PSN | 575c38b4-7ec0-6d25-e053-2a91aa0a80fc | 6 |
| 1190572 | atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet | SCD | 575c38b4-7ec0-6d25-e053-2a91aa0a80fc | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-4063-3 | 68071406303 | 30 TABLET in 1 BOTTLE (68071-4063-3) | 30 tablet | 2017-08-22 | 0000-00-00 | No | No | Current |